{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:18:34Z","timestamp":1792001914246,"version":"4.4.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012352","name":"University of Milan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["24168"],"award-info":[{"award-number":["24168"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007802","name":"Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007802","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.molmed.2021.10.008","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T08:29:41Z","timestamp":1638433781000},"page":"67-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Thymic stroma and TFII-I: towards new targeted therapies"],"prefix":"10.1016","volume":"28","author":[{"given":"Pierluigi Giuseppe","family":"Manti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Trattaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Castaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Pezzali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Spaggiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Testa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2021.10.008_bb0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejca.2007.11.004","article-title":"Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy","volume":"44","author":"de Jong","year":"2008","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.molmed.2021.10.008_bb0010","doi-asserted-by":"crossref","first-page":"6372","DOI":"10.1038\/s41467-020-20082-7","article-title":"Reconstitution of a functional human thymus by postnatal stromal progenitor cells and natural whole-organ scaffolds","volume":"11","author":"Campinoti","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2021.10.008_bb0015","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41467-021-21346-6","article-title":"Single-cell transcriptional profiling of human thymic stroma uncovers novel cellular heterogeneity in the thymic medulla","volume":"12","author":"Bautista","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2021.10.008_bb0020","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ng.3016","article-title":"A specific missense mutation in TFII-I occurs at high frequency in thymic epithelial tumors","volume":"46","author":"Petrini","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2021.10.008_bb0025","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3390\/cancers12082032","article-title":"Primary driver mutations in TFII-I specific to the development of thymomas","volume":"12","author":"Higuchi","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.molmed.2021.10.008_bb0030","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.molcel.2006.09.005","article-title":"Opposing functions of TFII-I spliced isoforms in growth factor-induced gene expression","volume":"24","author":"Hakre","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2021.10.008_bb0035","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1038\/s41418-020-0502-7","article-title":"Mutant TFII-I induces cell transformation and metabolic alterations in thymic epithelial cells","volume":"27","author":"Kim","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.molmed.2021.10.008_bb0040","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jtcvs.2020.01.019","article-title":"Commentary: dangerous liaisons \u2013 paraneoplastic syndromes and thymoma","volume":"160","author":"Ruffini","year":"2020","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.molmed.2021.10.008_bb0045","series-title":"The Human Thymus. Histophysiology and Pathology","author":"M\u00fcller-Hermelink","year":"1986"},{"key":"10.1016\/j.molmed.2021.10.008_bb0050","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00428-006-0218-1","article-title":"Atypical thymoma (WHO B3) with neuroendocrine differentiation: report of a case","volume":"449","author":"Shiraishi","year":"2006","journal-title":"Virchows Arch."},{"key":"10.1016\/j.molmed.2021.10.008_bb0055","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0046-8177(98)90112-5","article-title":"Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma","volume":"29","author":"Hishima","year":"1998","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.molmed.2021.10.008_bb0060","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0046-8177(87)80388-X","article-title":"Massive thymic hyperplasia with myoid cell differentiation","volume":"18","author":"Judd","year":"1987","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.molmed.2021.10.008_bb0065","doi-asserted-by":"crossref","first-page":"174-18","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molmed.2021.10.008_bb0070","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ccell.2018.01.003","article-title":"The integrated genomic landscape of thymic epithelial tumors","volume":"33","author":"Radovich","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molmed.2021.10.008_bb0075","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJMoa0905955","article-title":"Limbal stem-cell therapy and long-term corneal regeneration","volume":"363","author":"Rama","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2021.10.008_bb0080","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature24487","article-title":"Regeneration of the entire human epidermis using transgenic stem cells","volume":"551","author":"Hirsch","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2021.10.008_bb0085","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1182\/blood-2016-02-698977","article-title":"Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas","volume":"128","author":"Vallois","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2021.10.008_bb0090","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/gcc.22478","article-title":"Soft tissue angiofibroma: clinicopathologic, immunohistochemical and molecular analysis of 14 cases","volume":"56","author":"Bekers","year":"2017","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.molmed.2021.10.008_bb0095","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/bjh.13157","article-title":"GTF2I\u2013RARA is a novel fusion transcript in a t(7;17) variant of acute promyelocytic leukaemia with clinical resistance to retinoic acid","volume":"168","author":"Li","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.molmed.2021.10.008_bb0100","article-title":"A new GTF2I\u2013BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma","volume":"12","author":"Tomi\u0107","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2021.10.008_bb0105","doi-asserted-by":"crossref","first-page":"7336","DOI":"10.1038\/srep07336","article-title":"Mutations of epigenetic regulatory genes are common in thymic carcinomas","volume":"4","author":"Wang","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2021.10.008_bb0110","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/emmm.200900003","article-title":"Induced chromosome deletions cause hypersociability and other features of Williams\u2013Beuren syndrome in mice","volume":"1","author":"Li","year":"2009","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.molmed.2021.10.008_bb0115","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41572-021-00276-z","article-title":"Williams syndrome","volume":"7","author":"Kozel","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.molmed.2021.10.008_bb0120","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ng.3169","article-title":"7q11.23 dosage-dependent dysregulation in human pluripotent stem cells affects transcriptional programs in disease-relevant lineages","volume":"47","author":"Adamo","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2021.10.008_bb0125","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1597\/12-069","article-title":"ChIP-Chip identifies SEC23A, CFDP1, and NSD1 as TFII-I target genes in human neural crest progenitor cells","volume":"50","author":"Makeyev","year":"2013","journal-title":"Cleft Palate Craniofac. J."},{"key":"10.1016\/j.molmed.2021.10.008_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044443","article-title":"Diversity and complexity in chromatin recognition by TFII-I transcription factors in pluripotent embryonic stem cells and embryonic tissues","volume":"7","author":"Makeyev","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2021.10.008_bb0135","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/jmg.2009.071712","article-title":"Partial 7q11.23 deletions further implicate TFII-I and TFII-IRD1 as the main genes responsible for the Williams\u2013Beuren syndrome neurocognitive profile","volume":"47","author":"Antonell","year":"2010","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.molmed.2021.10.008_bb0140","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1096\/fj.07-104455","article-title":"The complex of TFII-I, PARP1, and SFPQ proteins regulates the DYX1C1 gene implicated in neuronal migration and dyslexia","volume":"22","author":"Tapia-P\u00e1ez","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.molmed.2021.10.008_bb0145","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1074\/jbc.M206528200","article-title":"Histone deacetylase 3 binds to and regulates the multifunctional transcription factor TFII-I","volume":"278","author":"Wen","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2021.10.008_bb0150","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/bjc.2011.75","article-title":"Multifunctional transcription factor TFII-I is an activator of BRCA1 function","volume":"104","author":"Tanikawa","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.molmed.2021.10.008_bb0155","doi-asserted-by":"crossref","first-page":"9006","DOI":"10.1073\/pnas.0803051105","article-title":"Identification of the TFII-I family target genes in the vertebrate genome","volume":"105","author":"Chimge","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2021.10.008_bb0160","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.gene.2011.10.030","article-title":"Biochemistry and biology of the inducible multifunctional transcription factor TFII-I: 10 years later","volume":"492","author":"Roy","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.molmed.2021.10.008_bb0165","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.molmed.2017.04.002","article-title":"Pathophysiology of TFII-I: old guard wearing new hats","volume":"23","author":"Roy","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.molmed.2021.10.008_bb0170","first-page":"7169","article-title":"TFII-I-mediated polymerase pausing antagonizes GLI2 induction by TGF\u03b2","volume":"48","author":"McCleary-Wheeler","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2021.10.008_bb0175","doi-asserted-by":"crossref","first-page":"8246","DOI":"10.1038\/s41598-021-87632-x","article-title":"Spatiotemporal 7q11.23 protein network analysis implicates the role of DNA repair pathway during human brain development","volume":"11","author":"Chen","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2021.10.008_bb0180","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.bbaexp.2007.10.002","article-title":"Signal-induced functions of the transcription factor TFII-I","volume":"1769","author":"Roy","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molmed.2021.10.008_bb0185","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/ng.2779","article-title":"A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sj\u00f6gren\u2019s syndrome at 7q11.23","volume":"45","author":"Li","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2021.10.008_bb0190","first-page":"632","article-title":"Association of GTF2I and GTF2IRD1 polymorphisms with systemic lupus erythematosus in a Chinese Han population","volume":"33","author":"Li","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.molmed.2021.10.008_bb0195","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016716","article-title":"Association of GTF2I gene polymorphisms with renal involvement of systemic lupus erythematosus in a Chinese population","volume":"98","author":"Meng","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.molmed.2021.10.008_bb0200","doi-asserted-by":"crossref","first-page":"27563","DOI":"10.1038\/srep27563","article-title":"Association-heterogeneity mapping identifies an Asian-specific association of the TFII-I locus with rheumatoid arthritis","volume":"6","author":"Kim","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2021.10.008_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.577045","article-title":"The TFII-I rs117026326 polymorphism is associated with neuromyelitis optica spectrum disorder but not with multiple sclerosis in a Northern Han Chinese population","volume":"337","author":"Liang","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.molmed.2021.10.008_bb0210","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1471-2415-14-106","article-title":"Paraneoplastic neuromyelitis optica associated with ANNA-1 antibodies in invasive thymoma","volume":"14","author":"Yang","year":"2014","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.molmed.2021.10.008_bb0215","doi-asserted-by":"crossref","first-page":"vi131","DOI":"10.1093\/annonc\/mdz343.062","article-title":"Thymoma associated with neuromyelitis optica spectrum disorder: a case report","volume":"30","author":"Watcharenwong","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.molmed.2021.10.008_bb0220","article-title":"Association of TFII-I, NFKB1, and TYK2 regional polymorphisms with systemic sclerosis in a Chinese Han population","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2021.10.008_bb0225","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/jcp.29928","article-title":"Multiomics data reveals the influences of myasthenia gravis on thymoma and its precision treatment","volume":"236","author":"Ruan","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.molmed.2021.10.008_bb0230","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1200\/JCO.2010.32.4467","article-title":"Phase II study of belinostat in patients with recurrent or refractory advanced thymic epithelial tumors","volume":"29","author":"Giaccone","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.molmed.2021.10.008_bb0235","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.1158\/1078-0432.CCR-14-0968","article-title":"A phase I\/II trial of belinostat in combination with cisplatin, doxorubicin, and cyclophosphamide in thymic epithelial tumors: a clinical and translational study","volume":"20","author":"Thomas","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.molmed.2021.10.008_bb0240","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13229-020-00387-6","article-title":"High-throughput screening identifies histone deacetylase inhibitors that modulate TFII-I expression in 7q11.23 microduplication autism spectrum disorder patient-derived cortical neurons","volume":"11","author":"Cavallo","year":"2020","journal-title":"Mol. Autism"},{"key":"10.1016\/j.molmed.2021.10.008_bb0245","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1200\/JCO.2017.74.4078","article-title":"Phase II study of everolimus in patients with thymoma and thymic carcinoma previously treated with cisplatin-based chemotherapy","volume":"36","author":"Zucali","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.molmed.2021.10.008_bb0250","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1470-2045(13)70596-5","article-title":"Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial","volume":"15","author":"Rajan","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.molmed.2021.10.008_bb0255","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/annonc\/mdu527","article-title":"Available evidence and new biological perspectives on medical treatment of advanced thymic epithelial tumors","volume":"26","author":"Serpico","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.molmed.2021.10.008_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102014","article-title":"Thymic epithelial tumors: from biology to treatment","volume":"86","author":"Conforti","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.molmed.2021.10.008_bb0265","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.1158\/0008-5472.CAN-17-1323","article-title":"Therapeutic effects of XPO1 inhibition in thymic epithelial tumors","volume":"77","author":"Conforti","year":"2017","journal-title":"Cancer Res."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149142100294X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149142100294X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:50:03Z","timestamp":1778521803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147149142100294X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S147149142100294X"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2021.10.008","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thymic stroma and TFII-I: towards new targeted therapies","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2021.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}